NO20090395L - Farmasoytiske preparater inneholdende monoklonale antidiotype anti-CA-125-antistoff og aluminiumderivater - Google Patents

Farmasoytiske preparater inneholdende monoklonale antidiotype anti-CA-125-antistoff og aluminiumderivater

Info

Publication number
NO20090395L
NO20090395L NO20090395A NO20090395A NO20090395L NO 20090395 L NO20090395 L NO 20090395L NO 20090395 A NO20090395 A NO 20090395A NO 20090395 A NO20090395 A NO 20090395A NO 20090395 L NO20090395 L NO 20090395L
Authority
NO
Norway
Prior art keywords
antibody
pharmaceutical preparations
preparations containing
containing anti
monoclonal antibody
Prior art date
Application number
NO20090395A
Other languages
English (en)
Norwegian (no)
Inventor
Jens Flemming
Karsten Groger
Reinhard Schmitz
Stefano Manzini
Original Assignee
Menarini Int Operations Lu Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Menarini Int Operations Lu Sa filed Critical Menarini Int Operations Lu Sa
Publication of NO20090395L publication Critical patent/NO20090395L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/39566—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against immunoglobulins, e.g. anti-idiotypic antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
NO20090395A 2006-06-29 2009-01-27 Farmasoytiske preparater inneholdende monoklonale antidiotype anti-CA-125-antistoff og aluminiumderivater NO20090395L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000163A ITFI20060163A1 (it) 2006-06-29 2006-06-29 Composizione farmaceutica contenente un anticorpo monoclonale anti idiotipico anti-ca-125 ed alluminio
PCT/EP2007/056465 WO2008000789A2 (fr) 2006-06-29 2007-06-28 Compositions pharmaceutiques contenant un anticorps monoclonal anti-idiotypique anti-ca-125 et de l'aluminium

Publications (1)

Publication Number Publication Date
NO20090395L true NO20090395L (no) 2009-01-27

Family

ID=37439367

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20090395A NO20090395L (no) 2006-06-29 2009-01-27 Farmasoytiske preparater inneholdende monoklonale antidiotype anti-CA-125-antistoff og aluminiumderivater

Country Status (34)

Country Link
US (2) US20100040625A1 (fr)
EP (2) EP2228073A1 (fr)
JP (1) JP2009541448A (fr)
KR (1) KR20090024240A (fr)
CN (1) CN101478987A (fr)
AP (1) AP2009004741A0 (fr)
AR (1) AR061364A1 (fr)
AT (1) ATE502649T1 (fr)
AU (1) AU2007263690A1 (fr)
BR (1) BRPI0713343A2 (fr)
CA (1) CA2655733A1 (fr)
CL (1) CL2007001888A1 (fr)
CR (1) CR10589A (fr)
CY (1) CY1111527T1 (fr)
DE (1) DE602007013402D1 (fr)
DK (1) DK2040749T3 (fr)
EA (1) EA015543B1 (fr)
EC (1) ECSP099089A (fr)
ES (1) ES2363616T3 (fr)
HR (1) HRP20110413T1 (fr)
IL (1) IL196148A0 (fr)
IT (1) ITFI20060163A1 (fr)
MA (1) MA30691B1 (fr)
MX (1) MX2008016059A (fr)
NO (1) NO20090395L (fr)
PE (1) PE20080269A1 (fr)
PL (1) PL2040749T3 (fr)
PT (1) PT2040749E (fr)
RS (1) RS51683B (fr)
SI (1) SI2040749T1 (fr)
TN (1) TNSN08485A1 (fr)
UA (1) UA95806C2 (fr)
WO (1) WO2008000789A2 (fr)
ZA (1) ZA200900563B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8658773B2 (en) 2011-05-02 2014-02-25 Immunomedics, Inc. Ultrafiltration concentration of allotype selected antibodies for small-volume administration
US20160279239A1 (en) 2011-05-02 2016-09-29 Immunomedics, Inc. Subcutaneous administration of anti-cd74 antibody for systemic lupus erythematosus and autoimmune disease
US20160355591A1 (en) 2011-05-02 2016-12-08 Immunomedics, Inc. Subcutaneous anti-hla-dr monoclonal antibody for treatment of hematologic malignancies
ITFI20060163A1 (it) * 2006-06-29 2006-09-28 Menarini Internat Operations Luxembourg Sa Composizione farmaceutica contenente un anticorpo monoclonale anti idiotipico anti-ca-125 ed alluminio
US10799597B2 (en) 2017-04-03 2020-10-13 Immunomedics, Inc. Subcutaneous administration of antibody-drug conjugates for cancer therapy

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5127731B1 (fr) * 1971-05-12 1976-08-14
FR2565825B1 (fr) * 1984-06-15 1990-07-13 Centre Nat Rech Scient Vaccin contre les maladies dues a des microorganismes tels que des mycoplasmes, sa preparation et membranes de microorganismes en tant que principe actif
WO1994027637A1 (fr) * 1993-05-27 1994-12-08 Uwe Wagner Anticorps monoclonaux anti-ca125 et antiidiotypiques, et compositions pharmaceutiques les contenant
US5690942A (en) * 1995-06-02 1997-11-25 American Home Products Corporation Adjuvants for viral vaccines
US5718904A (en) * 1995-06-02 1998-02-17 American Home Products Corporation Adjuvants for viral vaccines
GB9808485D0 (en) * 1998-04-21 1998-06-17 Univ Cambridge Tech Improvements relating to immunotherapy
US6586403B1 (en) * 2000-07-20 2003-07-01 Salpep Biotechnology, Inc. Treating allergic reactions and inflammatory responses with tri-and dipeptides
US6585981B1 (en) * 2000-07-27 2003-07-01 Regents Of The University Of Minnesota Temperature-sensitive live vaccine for Mycoplasma hyopneumoniae
CU23007A1 (es) * 2001-04-06 2004-12-17 Ct De Inmunologia Molecular Ct De Inmunologia Mole Combinaciones inmunoterapéuticas para el tratamiencombinaciones inmunoterapéuticas para el tratamiento de tumores que sobre-expresan gangliósidos to de tumores que sobre-expresan gangliósidos
US7537767B2 (en) * 2003-03-26 2009-05-26 Cytis Biotechnology Ag Melan-A- carrier conjugates
ITFI20060163A1 (it) * 2006-06-29 2006-09-28 Menarini Internat Operations Luxembourg Sa Composizione farmaceutica contenente un anticorpo monoclonale anti idiotipico anti-ca-125 ed alluminio

Also Published As

Publication number Publication date
EA200900085A1 (ru) 2009-06-30
AP2009004741A0 (en) 2009-02-28
PL2040749T3 (pl) 2011-09-30
EP2228073A1 (fr) 2010-09-15
ECSP099089A (es) 2009-02-27
DK2040749T3 (da) 2011-06-14
CR10589A (es) 2009-03-30
ITFI20060163A1 (it) 2006-09-28
ZA200900563B (en) 2010-03-31
WO2008000789A3 (fr) 2008-02-28
AR061364A1 (es) 2008-08-20
BRPI0713343A2 (pt) 2012-03-13
EP2040749B1 (fr) 2011-03-23
HK1126417A1 (en) 2009-09-04
KR20090024240A (ko) 2009-03-06
ATE502649T1 (de) 2011-04-15
UA95806C2 (ru) 2011-09-12
US20090104184A1 (en) 2009-04-23
SI2040749T1 (sl) 2011-06-30
MA30691B1 (fr) 2009-09-01
DE602007013402D1 (de) 2011-05-05
MX2008016059A (es) 2009-01-15
US20100040625A1 (en) 2010-02-18
PE20080269A1 (es) 2008-05-09
CA2655733A1 (fr) 2008-01-03
ES2363616T3 (es) 2011-08-10
CN101478987A (zh) 2009-07-08
PT2040749E (pt) 2011-06-30
EP2040749A2 (fr) 2009-04-01
CY1111527T1 (el) 2015-08-05
RS51683B (sr) 2011-10-31
EA015543B1 (ru) 2011-08-30
HRP20110413T1 (hr) 2011-07-31
JP2009541448A (ja) 2009-11-26
CL2007001888A1 (es) 2008-04-18
WO2008000789A2 (fr) 2008-01-03
AU2007263690A1 (en) 2008-01-03
TNSN08485A1 (en) 2010-04-14
IL196148A0 (en) 2011-08-01

Similar Documents

Publication Publication Date Title
NO20083895L (no) Anti-IGF-1R human monoklonalantibody formulering
MX393384B (es) Adyuvantes sinteticos de glucopiranosil-lipido.
EA200870545A1 (ru) Новые гетероциклические соединения
BRPI0520669A2 (pt) dosagem farmacêutica que reduz o efeito do alimento encontrado para administração de atorvastatina
EP2056861A4 (fr) Immunothérapie par vaccin
NO20170633A1 (no) Forbindelser av indolamin-2,3-dioksygenase for anvendelse i behandling av kreft i kombinasjon med et anti-PD-1 antistoff .
CY1114892T1 (el) Φαρμακευτικη συνθεση ενος ισχυρου αναστολεα του hcv για απο του στοματος χορηγηση
EA200970585A1 (ru) Бензамидные производные как агонисты ер-рецепторов
CL2010001426A1 (es) Compuestos derivados de triciclos, inhibidores de la proteina quinasa; composicion farmaceutica que los comprende; utiles en el tratamiento de enfermedades oncologicas e inmunologicas.
NO20084752L (no) Konjugater av aziridinayl-epotilonanaloger og farmasoytiske sammensetninger som inneholder disse
NO20080246L (no) Anti-IGF1R-antistofformuleringer
AR058433A1 (es) Derivado de 1,1-dioxido de 1,4-benzotiazepina ,procedimiento para su preparacion ,medicamentos que comprenden este compuesto y su uso
CO6341565A2 (es) Inhibidores macrociclicos de serina proteasas de hepatitis c
CL2008002295A1 (es) Compuestos derivados de tiazolida sustituidos con alquilsulfonilos; composicion farmaceutica; y uso para el tratamiento de la hepatitis c.
ECSP088296A (es) Compuestos terapéuticos
BRPI0610359B8 (pt) compostos de diaril-hidantoína, suas composições farmacêuticas e sais farmaceuticamente aceitáveis
CL2008001258A1 (es) Kit de vacuna que comprende al menos nueve conjugados de sacaridos de antgenos hb o hib, donde al menos 2-7 son con la proteina transportadora crm, siendo dicho kit adecuado para usar en su calendario de inmunizacion primaria; vacuna combinada adecuada para la inmunizacion primaria.
BRPI0714885B8 (pt) compostos terapêuticos e seu uso
BRPI0713031B8 (pt) composto de di-hidro-piran-2-ona, composição farmacêutica, e uso dos mesmos
NO20074933L (no) Farmasoytisk sammensetning som innbefatter et indolylmaleimidderivat
NO20090395L (no) Farmasoytiske preparater inneholdende monoklonale antidiotype anti-CA-125-antistoff og aluminiumderivater
ECSP045493A (es) Nuevas composiciones farmacéuticas que contienen flibanserina polimorfo a
BRPI0606506A2 (pt) polipeptìdeos de yersinia spp. e métodos de uso
CR9391A (es) Derivados de indanil-piperazinas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
AR049681A1 (es) Macrolidos preparados a partir de actinomicetos. composiciones farmaceuticas

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application